In vitro and in vivo interactions of cells with biomaterials

Biomaterials

Volumn 9, Issue 1, 1988, Pages 5-13

  Ziats, Nicholas P ^a   Miller, Kathleen M ^a   Anderson, James M ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

biocompatibility; cell polymer interactions; endothelium; fibroblasts; foreign body giant cells; Implants; macrophages; osteoblasts; osteoclasts

Indexed keywords

BIOMATERIAL;

ENDOTHELIUM CELL; FIBROBLAST; FOREIGN BODY REACTION; MACROPHAGE; NONHUMAN; OSTEOBLAST; REVIEW;

ANIMAL; BIOCOMPATIBLE MATERIALS; BONE AND BONES; CELL COMMUNICATION; CELL PHYSIOLOGY; ENDOTHELIUM; FIBROBLASTS; FOREIGN-BODY REACTION; HUMAN; MACROPHAGES;

EID: 0023848647     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/0142-9612(88)90063-4     Document Type: Article

References (112)

1. The tissue response to implants and its evaluation by light microscopy
2. Biomaterial biocompatibility and the macrophage
3. Regulation and reason for biocompatibility testing
4. In vivo biocompatibility studies. I. The cage implant system and a biodegradable hydrogel
5. In vivo biocompatibility studies. II. Biomer: preliminary cell adhesion and surface characterization studies
6. in vivo biocompatibility studies. V. in vivo leukocyte interactions with Biomer
7. Selectedaspects of cell and molecular biology of in vivo biocompatibility
8. Platelet interactions with biomaterials and artificial organs
9. in vivo leucocyte interactions with NHLBI-DTB primary reference materials: Polyethylene and silica-free polydimethylsiloxane
10. Current view on the mononuclear phagocyte system
11. The mononuclear phagocytic system: a review
12. Molecular mediators of tissue repair
13. Some aspects of macrophage behaviour at the implant interface
14. Quantitative characterization of cells at the interface of long-term implants of selected polymers
15. Macrophage nomenclature where are we going?
16. The cell biology of macrophage activation
17. Activation of macrophages — identification of molecular elements involved in regulation
18. Secretory productions of mononuclear phagocytes: a brief review
19. Secretory products of macrophages and their physiologic functions
20. Secretory products of macrophages
21. Role of macrophages in wound healing
22. The role of macrophages in wound repair: a review
23. Mesenchmal cell proliferation in wound repair: the role of macrophages
24. Proliferative diseases
25. How is blood vessel growth regulated in normal and neoplastic tissue?—(G.H.A.: Clowes Memorial Award Lecture)
26. The pathogenesis of atherosclerosis — an update
27. Pathogenesis of scleroderma (systemic sclerosis)
28. Current concepts of the pathogenesis of fibrosis: lessons from pulmonary fibrosis
29. Cellular immune mechanisms in human glomerulonephritis: the role of mononuclear leukocytes
30. Peptide growth factors and inflammation, tissue repair and cancer
31. Macrophage-derived growth factors for mesenchymal cells
32. A significant part of macrophage-derived growth factor consists of at least two forms of PDGF
33. Activated human monocytes express the c-sis proto-oncogene and release a mediator showing PDGF-like activity
34. Spontaneous expression of the c-sis and release of a platelet-derived growth factor-like molecule by human alveolar macrophages
35. Human transforming growth factor-β complementing DNA sequence and expression in normal and transformed cells
36. Immunoreactive fibroblast growth factors in cells of peritoneal exudate suggests its identity with macrophage-derived growth factor
37. Recombinant human tumor necrosis factor-α: effects on proliferation of normal and transformed cells in vitro
38. Interleukin 1, a potential regulator of fibroblast proliferation
39. Stimulation of fibroblast proliferation and prostaglandin production by recombinant murine Interleukin 1
40. Silica-stimulated monocytes release fibroblast proliferation factors identical to Interleukin 1. A potential role for Interleukin 1 in the pathogenesis of silicosis
41. Plasma Interleukin-1 activity in humans undergoing hemodialysis with regenerated cellulosic membranes
42. Macrophage activation with multi-porous beads prepared from partially deacetylated chitin
43. How the macrophage regulates its extracellular environment
44. Macrophage secretory products and connective tissue remodelling: role of macrophage enzymes and of ‘matrix regulatory monokines’
45. Cellular enzyme activity at the polymer-tissue interface; a review
46. The granulomatous inflammatory response: a review
47. The foreign body response: a chronic inflammatory response
48. Direct evidence that inflammatory multinucleate giant cells form by fusion
49. Functional and biochemical studies of multinucleated giant cells from the culture of human monocytes
50. The formation and properties of macrophage polykaryons (inflammatory giant cells)
51. Evidence that multinucleate giant cells are examples of mononuclear phagocytic differentiation
52. The microscopic characterization of multinucleated giant cells formed on polymeric surfaces perfused with blood
53. Fibroblast stimulation in schistosomiasis. II. Functional and biochemical characteristics of egg granuloma-derived fibroblast-stimulating factor
54. Fibroblast stimulation in schistosomiasis. IV. Isolated egg granulomas elaborate a fibroblast chemoattractant in vitro
55. Fibroblast stimulation in schistosomiasis. V. Egg granuloma macrophages spontaneously secrete a fibroblast-stimulating factor
56. Structure-function relationships in bone: an examination of events at the cellular level
57. Skeletal effects of parathyroid hormone
58. Wound healing: bone and bone materials
59. Growth factors which affect bone
60. Bone cell differentiation and growth factors
61. Macrophage derived growth factor for osteoblast-like cells and chondrocytes
62. Fracture healing perspectives
63. Stimulation of the proliferation of human bone cells in vitro by human monocyte products with lnterleukin-1 activity
64. Effects of endothelial cell growth factor on bone remodelling in vitro
65. Stimulation of bone resorption and inhibition of bone formation In vitro by human tumour necrosis factors
66. Foreign body reaction to polymeric debris following total hip arthroplasty
67. The fibroblast in morphogenesis and fibrosis: cell topography and surface related functions
68. The myofibroblast: a key cell for wound healing and fibrocontractive diseases
69. Origin of myofibroblasts in the avascular capsule around free-floating intraperitoneal blood clots
70. Cell adhesion to biomaterials. The role of several extracellular matrix components in the attachment of non-transformed fibroblasts and parenchymal cells
71. Cellular interactions with synthetic polymer surfaces in culture
72. in vivo quantification of cell-polymer interactions
73. Regulation of fibroblast proliferation and collagen synthesis by cytokines
74. Conditioning surfaces to suit the biomedical environment
75. Vascular endothelium: nature's blood container
76. Artificial devices in clinical practice
77. Leukocyte-endothelial interactions
78. Vascular endothelium as a major participant in T-lymphocyte immunity
79. Induction and detection of a human endothelial activation antigen in vivo
80. Interleukin 1 increases the binding of human B and T-lymphocytes to endothelial cell monolayers
81. Two distinct monokines, Interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells
82. Interleukin-1 activation of vascular endothelium. Effects on procoagulant activity and leukocyte adhesion
83. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells
84. Interleukin 1 acts on cultued human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes monocytes and related leukocyte cell lines
85. Exaggerated human vascular cell prostaglandin biosynthesis mediated by monocytes: role of monokines and interleukin 1
86. The fibrinolytic system of cultured endothelial cells: insights into the role of endothelium in thrombolysis
87. Regulation of the fibrinolytic system of cultured human vascular endothelium by Interleukin 1
88. Prostacyclin synthesis induced in vascular cells by lnterleukin-1
89. Induction of neovascularization in vivo and endothelial proliferation by tumor-associated macrophages
90. Comparison of the neovascular effects of stimulated macrophages and neutrophils in autologous rabbit corneas
91. Induction of neovascularization by activated human monocytes
92. The biology of plateletderived growth factor
93. Tumor necrosis factor and interleukin 1:cytokines with multiple overlapping biological activities
94. TGF-β inhibition of endothelial cell proliferation: alteration of EGF binding and EGFinduced growth-regulatory (competence) gene expression
95. There is more than one Interleukin 1
96. Cultured endothelial cells produce multiple growth factors for connective tissue cells
97. Inducible interleukin-1 gene expression in human vascular smooth muscle cells
98. Heparin protects basic and acidic FGF from inactivation
99. Glomerular endothelial cells secrete a heparin-like inhibitor and a peptide stimulator of mesangial cell proliferation
100. Human endothelial cells: use of heparin in cloning and long-term serial cultivation
101. The fibrinolytic system of the vascular wall
102. Smooth muscle cell proliferation and arterial graft failure
103. Procedures in the retrieval and evaluation of vascular grafts
104. Mechanisms of arterial graft failure. 1. Role of cellular proliferation in early healing of PTFE prostheses
105. Mechanisms of arterial graft healing. A rapid transmural capillary ingrowth provides a source of intimal endothelium and smooth muscle in porous PTFE prostheses
106. The development of cellular linings in artificial vascular prostheses
107. Endothelial cell seeded synthetic vascular grafts
108. Perspectives in vascular surgery — biocompatible vascular surfaces: the past and future role of endothelial cells
109. A single staged technique for seeding vascular grafts with autogenous endothelium
110. Why small caliber vascular grafts fail: a review of clinical and experimental experience and the significance of the interaction of blood at the interface